| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.62B | 15.15B | 13.15B | 13.71B | 15.69B | 16.34B |
| Gross Profit | 3.26B | 2.89B | 3.17B | 4.06B | 5.95B | 7.41B |
| EBITDA | 2.83B | 4.76B | 3.00B | 3.86B | 5.91B | 7.73B |
| Net Income | 1.82B | 2.32B | 1.79B | 5.12B | 3.26B | 3.11B |
Balance Sheet | ||||||
| Total Assets | 115.01B | 122.23B | 114.90B | 118.55B | 116.33B | 112.93B |
| Cash, Cash Equivalents and Short-Term Investments | 28.43B | 31.15B | 29.55B | 39.33B | 31.65B | 33.53B |
| Total Debt | 1.04B | 899.00M | 1.12B | 1.53B | 2.01B | 2.35B |
| Total Liabilities | 13.60B | 17.50B | 14.07B | 15.73B | 15.93B | 17.78B |
| Stockholders Equity | 100.80B | 104.09B | 100.23B | 102.23B | 99.84B | 94.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.35B | -1.01B | 1.56B | -746.00M | 2.88B |
| Operating Cash Flow | 0.00 | 5.73B | 442.00M | 2.81B | 921.00M | 5.14B |
| Investing Cash Flow | 0.00 | -2.91B | -5.32B | 7.23B | -1.51B | -2.29B |
| Financing Cash Flow | 0.00 | -1.10B | -4.96B | -2.36B | -1.29B | -1.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥96.02B | 32.32 | 1.46% | 1.18% | 15.23% | 37.37% | |
66 Neutral | ¥102.53B | 19.98 | ― | 2.19% | 3.42% | 7.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥104.44B | 5.44 | ― | 2.93% | 14.99% | 73.33% | |
61 Neutral | ¥113.56B | 8.03 | 15.81% | 2.93% | 12.51% | 12.42% | |
58 Neutral | ¥70.65B | 2.14 | ― | ― | 93.14% | 252.55% | |
56 Neutral | ¥78.69B | 8.44 | ― | 3.08% | 23.38% | 19.73% |